Tilray Brands (TLRY) Gains from Investment Securities (2019 - 2025)

Tilray Brands (TLRY) posted Gains from Investment Securities of -$15.0 million for Q3 2025, down 1600.0% on a QoQ basis from $1.0 million in Q2 2024.

Tilray Brands (TLRY) Gains from Investment Securities (2019 - 2025) Analysis & Trends

Tilray Brands' Gains from Investment Securities history runs 7 years deep, the most recent figure standing at -$15.0 million for Q3 2025.

  • Quarterly Gains from Investment Securities changed N/A year-over-year to -$15.0 million in Q3 2025, while the trailing twelve-month figure through Feb 2026 was -$15.0 million (down 1600.0% YoY) and the FY2024 annual result came in at -$15.8 million, down 1946.78% from the prior year.
  • Gains from Investment Securities was -$15.0 million for Q3 2025 at Tilray Brands, down from $1.0 million in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $1.0 million in Q2 2024 and bottomed at -$30.7 million in Q1 2022.
  • A 5-year average of -$6.2 million and a median of $251500.0 in 2022 frame the typical range for Gains from Investment Securities.
  • Annual changes were most pronounced in 2023 — Gains from Investment Securities tumbled 5363.98% — and 2024, when it jumped 242.47%.
  • Tilray Brands' Gains from Investment Securities stood at $845000.0 in 2021, then tumbled by 75.03% to $211000.0 in 2022, then soared by 42.18% to $300000.0 in 2023, then surged by 233.33% to $1.0 million in 2024, then tumbled by 1600.0% to -$15.0 million in 2025.
  • Business Quant data shows TLRY's Gains from Investment Securities at -$15.0 million in Q3 2025, $1.0 million in Q2 2024, and -$6.0 million in Q1 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 89.78 Bn 87.91 Bn -
2 Teva Pharmaceutical Industries 36.02 Bn 32.28 Bn 1.97 Bn
3 Zoetis 32.60 Bn 30.66 Bn 1.62 Bn
4 Takeda Pharmaceutical 27.54 Bn 23.48 Bn 4.39 Bn
5 United Therapeutics 23.09 Bn 20.94 Bn 648.10 Mn
6 RedHill Biopharma 21.48 Bn 21.48 Bn -
7 Viatris 20.35 Bn 18.54 Bn 1.16 Bn
8 Neurocrine Biosciences 17.82 Bn 16.50 Bn 800.70 Mn
9 Elanco Animal Health 12.64 Bn 12.21 Bn 785.00 Mn
10 Tilray Brands 450.71 Mn 390.52 Mn 54.95 Mn

Historic Data

Download Data
DateValue
Aug 31, 2025 -15.00 Mn
Aug 31, 2025 -15.00 Mn
May 31, 2024 1.00 Mn
May 31, 2024 1.00 Mn
Feb 29, 2024 -5.98 Mn
Feb 29, 2024 -5.98 Mn
Nov 30, 2023 300,000.00
Nov 30, 2023 300,000.00
Aug 31, 2023 -11.11 Mn
Aug 31, 2023 -11.11 Mn
May 31, 2023 292,000.00
May 31, 2023 292,000.00
Feb 28, 2023 352,000.00
Feb 28, 2023 352,000.00
Aug 31, 2022 211,000.00
Aug 31, 2022 211,000.00
May 31, 2022 -15.59 Mn
May 31, 2022 -15.59 Mn
Feb 28, 2022 -30.75 Mn
Feb 28, 2022 -30.75 Mn